Robert Stagg serves as Executive at OncoMed Pharmaceuticals Inc, where they oversee executive responsibilities. Since joining the company, Robert Stagg has executed 4 insider transactions totaling $16.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 23, 2019 involved transacting 28,917 shares valued at $0.
Robert Stagg currently holds 40,670 shares of OncoMed Pharmaceuticals Inc (OMED), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Stagg has been a net seller of OMED stock. They have purchased $0 and sold $16.3K worth of shares.
Robert Stagg's most recent insider trade was on Apr 23, 2019, when they sold 28,917 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.01 |
| Discretionary |
| Oct 9, 2018 | OMED | $3.6K | Sale | 1,686 | $2.13 | Discretionary |
| Apr 24, 2018 | OMED | $10.9K | Sale | 4,051 | $2.68 | Discretionary |